Cameco Corp. buy BiotechBee
Start price
03.10.22
/
50%
€28.02
Target price
31.12.24
€37.00
Performance (%)
-26.25%
End price
21.12.22
€20.67
Summary
This prediction ended on 21.12.22 with a price of €20.67. The prediction for Cameco Corp. disappointed with a performance of -26.25%. Dividends of €0.063 are taken into consideration when calculating the performance. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cameco Corp. | -0.523% | -0.523% | 45.701% | 269.870% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to BiotechBee what are the pros and cons of Cameco Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Cameco Corp. diskutieren
Buy mit Kursziel 37,0